Conyers Dill & Pearman advised SELLAS Life Sciences Group Ltd, on the continuation of the company from Zug, Switzerland to Bermuda. SELLAS is a late-stage biopharmaceutical firm which is focused on the development of novel products to treat a variety of cancers using the body’s own defences. The company has a close working relationship with the Memorial Sloan-Kettering Cancer Center in New York to progress research and trials for treatment on various types of cancer.
Guy Cooper from the Bermuda office of Conyers Dill & Pearman worked on the matter.
